AtaGenix Laboratories

Home - Support Center - FAQs

Stable Cell Line Development: CHO-K1, DG44, GS/MSX — Selection System Comparison

Release time: 2026-03-27   View volume: 10

Stable cell line development is essential for consistent, long-term recombinant protein and antibody production. The choice of CHO host cell and selection system directly impacts expression level, timeline, and scalability. This guide compares the three most common selection systems and helps you choose the right one.

Why develop a stable cell line instead of using transient expression?

Transient expression delivers protein fast (2–4 weeks) but yields vary batch-to-batch and aren’t sustainable long-term. Stable cell lines integrate the transgene into the host genome, providing consistent expression over 60+ generations with documented monoclonality — required for manufacturing, regulatory filings, and any project needing reproducible, high-titer production.

How do the three selection systems compare?

Feature G418 / Neomycin DHFR / MTX GS / MSX
Selection Mechanism Antibiotic resistance Gene amplification (MTX pressure) Metabolic selection (glutamine deprivation)
Host Cell CHO-K1 or any CHO CHO-DG44 (DHFR−/−) CHO-K1 or CHO-S
Expression Level Moderate High (amplification) High (stringent selection)
Selection Speed Fast (2–3 weeks) Slow (multiple amplification rounds) Moderate (4–6 weeks)
Gene Copy Amplification No Yes (MTX-driven) No (but high per-copy expression)
Stability Good Risk of instability without selection pressure Excellent (≥60 generations)
Best For Research-grade lines, fast screening High-expression, gene amplification needed Manufacturing, regulatory, high-producer isolation

What does a typical stable cell line project look like?

Vector Build (2 wk)
Transfection (1 wk)
Pool Selection (4 wk)
Single-Cell Cloning (3 wk)
Stability & QC (2 wk)

Total timeline is approximately 12 weeks from kickoff to Research Cell Bank (RCB). Deliverables include monoclonality documentation, stability data (≥60 generations), RCB, and full IP ownership transfer. AtaGenix supports all three selection systems with CHO-K1 and DG44 host cells.

Ready to develop a stable CHO cell line for your protein or antibody? AtaGenix delivers clonally-derived production lines in ~12 weeks with documented monoclonality and stability.

Talk to Technical Support

Response within 24 hours

Messages